Filing Details
- Accession Number:
- 0000886163-13-000088
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-09-04 19:10:38
- Reporting Period:
- 2013-08-30
- Filing Date:
- 2013-09-04
- Accepted Time:
- 2013-09-04 19:10:38
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
886163 | Ligand Pharmaceuticals Inc | LGND | Pharmaceutical Preparations (2834) | 770160744 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1392266 | S Charles Berkman | 11119 North Torrey Pines Road, Suite 200 La Jolla CA 92037 | Vp, Gen. Counsel & Secretary | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2013-08-30 | 9,499 | $21.00 | 27,427 | No | 4 | M | Direct | |
Common Stock | Disposition | 2013-08-30 | 9,499 | $47.54 | 17,928 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2013-08-30 | 11,804 | $16.14 | 29,732 | No | 4 | M | Direct | |
Common Stock | Disposition | 2013-08-30 | 11,804 | $47.54 | 17,928 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2013-08-30 | 7,020 | $14.47 | 24,948 | No | 4 | M | Direct | |
Common Stock | Disposition | 2013-08-30 | 7,020 | $47.54 | 17,928 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2013-08-30 | 3,834 | $21.00 | 21,762 | No | 4 | M | Direct | |
Common Stock | Acquisiton | 2013-08-30 | 4,862 | $16.14 | 26,624 | No | 4 | M | Direct | |
Common Stock | Acquisiton | 2013-08-30 | 312 | $10.05 | 26,936 | No | 4 | M | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | M | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Employee Stock Option (right to buy) | Disposition | 2013-08-30 | 312 | $0.00 | 312 | $10.05 |
Common Stock | Employee Stock Option (right to buy) | Disposition | 2013-08-30 | 7,020 | $0.00 | 7,020 | $14.47 |
Common Stock | Employee Stock Option (right to buy) | Disposition | 2013-08-30 | 11,804 | $0.00 | 11,804 | $16.14 |
Common Stock | Employee Stock Option (right to buy) | Disposition | 2013-08-30 | 4,862 | $0.00 | 4,862 | $16.14 |
Common Stock | Employee Stock Option (right to buy) | Disposition | 2013-08-30 | 9,499 | $0.00 | 9,499 | $21.00 |
Common Stock | Employee Stock Option (right to buy) | Disposition | 2013-08-30 | 3,834 | $0.00 | 3,834 | $21.00 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
5,625 | 2021-02-17 | No | 4 | M | Direct | |
2,850 | 2022-02-09 | No | 4 | M | Direct | |
4,862 | 2019-02-15 | No | 4 | M | Direct | |
0 | 2019-02-15 | No | 4 | M | Direct | |
3,834 | 2018-02-23 | No | 4 | M | Direct | |
0 | 2018-02-23 | No | 4 | M | Direct |
Footnotes
- Grant to reporting person of options, exercisable over a 4-year period measured from the date of grant, 12-1/2% after six months, then 1/48th of the Option Shares per month thereafter. The date of grant is 02/17/11.
- Grant to reporting person of options, exercisable over a 4-year period measured from the date of grant, 12-1/2% after six months, then 1/48th of the Option Shares per month thereafter. The date of grant is 02/09/12.
- Grant to reporting person of options, exercisable over a 4-year period measured from the date of grant, 12-1/2% after six months, then 1/48th of the Option Shares per month thereafter. The date of grant is 2/15/09.
- Grant to reporting person of options, exercisable over a 4-year period measured from the date of grant, 12-1/2% after six months, then 1/48th of the Option Shares per month thereafter. The date of grant is 2/23/08.